What Is the New Treatment for C. diff? Exploring Microbiome and Antibody Innovations
•
4 min read
Recurrent *Clostridioides difficile* (*C. diff*) infection affects approximately 1 in 5 patients who contract the illness. To combat this, the landscape of treatment is rapidly shifting away from repeated courses of antibiotics toward innovative, targeted therapies. These new approaches focus on restoring the gut microbiome and neutralizing the toxins responsible for infection, directly answering the question: 'What is the new treatment for C. diff?'.
